MarketBeat
10 May 2026, 19:05 UTC · 19w ago
Verdict
Headline takes no side. We score HAE +0.60 across six claims — strongly bullish.
+0.60strongly bullish
More positive than 74% of ticker scores this week
What the story claims
6 claims · scored −1 bearish … +1 bullish
Haemonetics issued fiscal 2027 guidance calling for only 0% to 2% Plasma collection volume growth, leaving significant upside potential if trends remain strong or Persona PLUS adoption accelerates.
So whatConservative baseline guidance for the largest growth driver creates a low hurdle for beats and raises, which is typically bullish for forward valuations if momentum continues.
More positive than 98% of claims this week
Interventional Technologies revenue declined 10% in Q4, but management stated that 80% of the headwinds have been lapped or reduced, signaling a potential turning point for the franchise.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More positive than 93% of claims this week
Full-year Plasma revenue grew 20% organically excluding CSL, exceeding the company's revised guidance range of 17% to 19%.
More positive than 86% of claims this week
Full-year adjusted gross margin expanded 280 basis points to 60.3% and adjusted operating margin expanded 140 basis points to 25.4%.
So whatMaterial margin expansion driven by portfolio transformation and volume leverage translates directly into disproportionate bottom-line growth and improved free cash flow generation.
More positive than 84% of claims this week
Which stocks this story touches
More positive than 74% of ticker scores this week
Reported organic revenue growth, record performance in Plasma and Blood Management, and provided positive guidance for fiscal 2027.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+94.9%
Price agrees with the score
$107.44 vs $55.12 close before publication (May 8) · not market-adjusted
HAE chart →
